| Authors: |
Silvestris N; IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, Italy; Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy. Electronic address: n.silvestris@oncologico.bari.it., Argentiero A; IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, Italy., Beretta GD; Medical Oncology Department, Humanitas Gavazzeni, Bergamo, Italy., Di Bartolo P; Diabetology Unit, Rete Clinica di Diabetologia Aziendale - Dipartimento, Internistico di Ravenna - AUSL Romagna, Ravenna, Italy., Montagnani M; Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy., Danesi R; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Italy., Ferrari P; Palliative Care Unit, Istituti Clinici Scientifici Maugeri SPA SB, IRCCS (PV), Italy., D'Oronzo S; IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, Italy; Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy., Gori S; Oncologia Medica, IRCCS Ospedale Don Calabria-Sacro Cuore di Negrar, Verona, Italy., Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Italy., Acquati S; Endocrinology Unit, Ospedale Pierantoni-Morgagni, Forlì, Italy., Gallo M; Oncological Endocrinology Unit, Department of Medical Sciences, University of Torino, AOU Città della Salute e della Scienza di Torino, Torino, Italy. |
